Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The classification of mood disorders lacks precision and consequently there has been no recent meaningful advance in their treatment. By virtue of its therapeutic specificity, lithium responsivity offers an opportunity to diagnose a definitive subtype of mood disorders that may provide a platform for the development of targeted therapy.

Original publication

DOI

10.1192/bjp.bp.114.148072

Type

Journal article

Journal

Br J Psychiatry

Publication Date

11/2014

Volume

205

Pages

337 - 339

Keywords

Antimanic Agents, Bipolar Disorder, Humans, Lithium